home > drugs a-z list > trilipix (fenofibric acid capsule) drug center > trilipix (fenofibric acid capsule) drug - overdosage and contraindications

There is no specific treatment for overdose with Trilipix. General supportive care of the patient is indicated, including monitoring of vital signs and observation of clinical status, should an overdose occur. If indicated, elimination of unabsorbed drug should be achieved by emesis or gastric lavage; usual precautions should be observed to maintain the airway. Because Trilipix is highly bound to plasma proteins, hemodialysis should not be considered.

Trilipix is contraindicated in:

• patients with severe renal impairment, including those receiving dialysis.
• patients with active liver disease, including those with primary biliary cirrhosis and unexplained persistent liver function abnormalities.
• patients with preexisting gallbladder disease.
• nursing mothers.
• patients with hypersensitivity to fenofibric acid, choline fenofibrate or fenofibrate [see WARNINGS AND PRECAUTIONS].

When Trilipix is co-administered with a statin, refer to the Contraindications section of the respective statin labeling.

Last reviewed on RxList: 10/12/2011
This monograph has been modified to include the generic and brand name in many instances.